Journal article
Trastuzumab-related cardiotoxicity: What do we know in 2020?
J Liu, S Goel, JMN Beith
Translational Cancer Research | AME PUBLISHING COMPANY | Published : 2020
DOI: 10.21037/tcr-20-2188
Open access
Abstract
Trastuzumab-related cardiotoxicity: what do we know in 2020?
Grants
Funding Acknowledgements
All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr-20-2188).JL received grant funding from Astra Zeneca for unrelated research. SG has received research funding from Eli Lilly and G1 Therapeutics, and has served as an advisor to Eli Lilly and Novartis. JMB has served on Advisory Boards for Roche, Lilly, Novartis and Pfizer with payment to her Institution. Travel funded by Roche.